401
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

An evaluation of tocotrienol ethosomes for transdermal delivery using Strat-M® membrane and excised human skin

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 243-251 | Received 22 Aug 2020, Accepted 02 Dec 2020, Published online: 15 Dec 2020

References

  • Aggarwal BB, Kumar A, Bharti AC. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23(1A):363–398.
  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. 2013. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment. Int J Pharm. 443(1–2):26–38.
  • Alqahtani S, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A. 2013. Nonlinear absorption kinetics of self-emulsifying drug delivery systems (SEDDS) containing tocotrienols as lipophilic molecules: in vivo and in vitro studies. AAPS J. 15(3):684–695.
  • Alqahtani S, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A. 2014. Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS). Lipids. 49(8):819–829.
  • Andrews SN, Jeong E, Prausnitz MR. 2013. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res. 30(4):1099–1109.
  • Avadhani KS, Manikkath J, Tiwari M, Chandrasekhar M, Godavarthi A, Vidya SM, Hariharapura RC, Kalthur G, Udupa N, Mutalik S. 2017. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Deliv. 24(1):61–74.
  • Barry BW. 2001. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci. 14(2):101–114.
  • Brownlow B, Nagaraj VJ, Nayel A, Joshi M, Elbayoumi T. 2015. Development and in vitro evaluation of vitamin E-enriched nanoemulsion vehicles loaded with genistein for chemoprevention against UVB-induced skin damage. J Pharm Sci. 104(10):3510–3523.
  • Dayan N, Touitou E. 2000. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 21(18):1879–1885.
  • Dubey V, Mishra D, Dutta T, Nahar M, Saraf D, Jain N. 2007. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 123(2):148–154.
  • Eaton P, Quaresma P, Soares C, Neves C, de Almeida MP, Pereira E, West P. 2017. A direct comparison of experimental methods to measure dimensions of synthetic nanoparticles. Ultramicroscopy. 182:179–190.
  • Fang Y-P, Tsai Y-H, Wu P-C, Huang Y-B. 2008. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy. Int J Pharm. 356(1–2):144–152.
  • Freitas C, Müller RH. 1998. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int J Pharm. 168(2):221–229.
  • Haq A, Dorrani M, Goodyear B, Joshi V, Michniak-Kohn B. 2018. Membrane properties for permeability testing: skin versus synthetic membranes. Int J Pharm. 539(1–2):58–64.
  • Hasan ZAA, Idris Z, Gani S, Basri M. 2018. In vitro safety evaluation of palm tocotrienol-rich fraction nanoemulsions for topical application. J Oil Palm Res. 30:150–162.
  • Heeremans JL, Gerritsen HR, Meusen SP, Mijnheer FW, Gangaram Panday RS, Prevost R, Kluft C, Crommelin DJ. 1995. The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target. 3(4):301–310.
  • Jose A, Labala S, Ninave KM, Gade SK, Venuganti VVK. 2018. Effective skin cancer treatment by topical co-delivery of curcumin and STAT3 siRNA using cationic liposomes. AAPS PharmSciTech. 19(1):166–175.
  • Kohli AK, Alpar HO. 2004. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm. 275(1–2):13–17.
  • Ling MT, Luk SU, Al-Ejeh F, Khanna KK. 2012. Tocotrienol as a potential anticancer agent. Carcinogenesis. 33(2):233–239.
  • Liu D, Hu H, Lin Z, Chen D, Zhu Y, Hou S, Shi X. 2013. Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J Photochem Photobiol B. 127:8–17.
  • Manickam B, Sreedharan R, Chidambaram K. 2019. Drug/vehicle impacts and formulation centered stratagems for enhanced transdermal drug permeation, controlled release and safety: unparalleled past and recent innovations-an overview. Curr Drug Ther. 14(3):192–209.
  • Marto J, Vitor C, Guerreiro A, Severino C, Eleutério C, Ascenso A, Simões S. 2016. Ethosomes for enhanced skin delivery of griseofulvin. Colloids Surf B Biointerfaces. 146:616–623.
  • Mba OI, Dumont M-J, Ngadi M. 2015. Palm oil: processing, characterization and utilization in the food industry – a review. Food Biosci. 10:26–41.
  • Nainwal N, Jawla S, Singh R, Saharan VA. 2019. Transdermal applications of ethosomes - a detailed review. J Liposome Res. 29(2):103–113.
  • Nair RS, Morris A, Billa N, Leong C-O. 2019. An evaluation of curcumin-encapsulated chitosan nanoparticles for transdermal delivery. AAPS PharmSciTech. 20(2):69.
  • Nair RS, Nair S. 2015. Permeation studies of captopril transdermal films through human cadaver skin. Curr Drug Deliv. 12(5):517–523.
  • Nzai JM, Proctor A. 1998. Determination of phospholipids in vegetable oil by Fourier transform infrared spectroscopy. J Amer Oil Chem Soc. 75(10):1281–1289.
  • Ogiso T, Yamaguchi T, Iwaki M, Tanino T, Miyake Y. 2001. Effect of positively and negatively charged liposomes on skin permeation of drugs. J Drug Targeting. 9(1):49–59.
  • Pandey V, Golhani D, Shukla R. 2015. Ethosomes: versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Deliv. 22(8):988–1002.
  • Pathan IB, Jaware BP, Shelke S, Ambekar W. 2018. Curcumin loaded ethosomes for transdermal application: formulation, optimization, in-vitro and in-vivo study. J Drug Delivery Sci Technol. 44:49–57.
  • Pham J, Nayel A, Hoang C, Elbayoumi T. 2016. Enhanced effectiveness of tocotrienol-based nano-emulsified system for topical delivery against skin carcinomas. Drug Deliv. 23(5):1514–1524.
  • Potts RO, Guy RH. 1992. Predicting skin permeability. Pharm Res. 9(5):663–669.
  • Ruela ALM, Perissinato AG, Lino MEdS, Mudrik PS, Pereira GR. 2016. Evaluation of skin absorption of drugs from topical and transdermal formulations. Braz J Pharm Sci. 52(3):527–544.
  • Sapra B, Jindal M, Tiwary AK. 2012. Tight junctions in skin: new perspectives. Ther Deliv. 3(11):1297–1327.
  • Scolari IR, Páez PL, Sánchez-Borzone ME, Granero GE. 2019. Promising chitosan-coated alginate-tween 80 nanoparticles as rifampicin coadministered ascorbic acid delivery carrier against Mycobacterium tuberculosis. AAPS PharmSciTech. 20(2):67.
  • Silva R, Ferreira H, Little C, Cavaco-Paulo A. 2010. Effect of ultrasound parameters for unilamellar liposome preparation. Ultrason Sonochem. 17(3):628–632.
  • Singh I, Nair RS, Gan S, Cheong V, Morris A. 2019. An evaluation of crude palm oil (CPO) and tocotrienol rich fraction (TRF) of palm oil as percutaneous permeation enhancers using full-thickness human skin. Pharm Dev Technol. 24(4):448–454.
  • Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. 2000. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 65(3):403–418.
  • Verma P, Pathak K. 2010. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 1(3):274–282.
  • Verma P, Pathak K. 2012. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 8(4):489–496.
  • Verma DD, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin. Int J Pharm. 258(1–2):141–151.
  • Williams AC, Barry BW. 2004. Penetration enhancers. Adv Drug Deliv Rev. 56(5):603–618.
  • Xie J, Ji Y, Xue W, Ma D, Hu Y. 2018. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery. Colloids Surf B Biointerfaces. 172:323–329.
  • Yamaguchi K, Mitsui T, Aso Y, Sugibayashi K. 2008. Structure-permeability relationship analysis of the permeation barrier properties of the stratum corneum and viable epidermis/dermis of rat skin. J Pharm Sci. 97(10):4391–4403.
  • Yang L, Wu L, Wu D, Shi D, Wang T, Zhu X. 2017. Mechanism of transdermal permeation promotion of lipophilic drugs by ethosomes. Int J Nanomed. 12:3357–3364.
  • Yu X, Du L, Li Y, Fu G, Jin Y. 2015. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel. Biomed Pharmacother. 73:6–11.
  • Zhai Y, Xu R, Wang Y, Liu J, Wang Z, Zhai G. 2015. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties. J Liposome Res. 25(4):316–324.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.